Adaptin Bio, Inc. Files 8-K
Ticker: APTN · Form: 8-K · Filed: Apr 9, 2025 · CIK: 1938571
| Field | Detail |
|---|---|
| Company | Adaptin Bio, Inc. (APTN) |
| Form Type | 8-K |
| Filed Date | Apr 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-event
TL;DR
Adaptin Bio filed an 8-K on 4/9 for an event on 4/7, no major details yet.
AI Summary
Adaptin Bio, Inc. filed an 8-K on April 9, 2025, reporting an event on April 7, 2025. The filing indicates a change in the company's status or operations, with no specific financial transactions or material agreements detailed in the provided text. The company was formerly known as Unite Acquisition 1 Corp. and was incorporated in Delaware.
Why It Matters
This 8-K filing signals a corporate event for Adaptin Bio, Inc., requiring public disclosure and potentially impacting investor understanding of the company's current status.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and does not disclose specific material risks or significant financial changes.
Key Players & Entities
- ADAPTIN BIO, INC. (company) — Registrant
- Unite Acquisition 1 Corp. (company) — Former Company Name
- April 7, 2025 (date) — Earliest event date
- April 9, 2025 (date) — Filing date
- Delaware (jurisdiction) — State of Incorporation
FAQ
What specific event occurred on April 7, 2025, that prompted this 8-K filing?
The provided text does not specify the exact nature of the 'Other Events' that occurred on April 7, 2025.
What was the former name of Adaptin Bio, Inc.?
The former name of Adaptin Bio, Inc. was Unite Acquisition 1 Corp.
In which state is Adaptin Bio, Inc. incorporated?
Adaptin Bio, Inc. is incorporated in Delaware.
What is the principal executive office address for Adaptin Bio, Inc.?
The principal executive office is located at 3540 Toringdon Way, Suite 200, #250, Charlotte, North Carolina 28277.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted on April 9, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 9, 2025 regarding ADAPTIN BIO, INC. (APTN).